Study of malignant fibrous histiocytoma: Clinical, statistic and histopatological interrelation

Romanian Journal of Morphology and Embryology

Volumn 52, Issue SUPPL. 1, 2011, Pages 385-388

  Pobirci, D D ^a   Bogdan, Florin ^b   Pobirci, Oana ^a   Petcu, Carmen Adina ^c   Roşca, Elena ^d  

^a UNIVERSITY OF ORADEA   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^c Hippocrat 2000 Clinic   (Romania)

^d University of Oradea   (Romania)

Author keywords

Bone infarcts; Bone tumors; Histiocytes; Malignant fibrous histiocytoma; Osteosarcoma; Secondary lesions

Indexed keywords

AGED; ARTICLE; FEMALE; FIBROSARCOMA; HUMAN; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MIDDLE AGED; PATHOLOGY; STATISTICS;

AGED; FEMALE; FIBROSARCOMA; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MALE; MIDDLE AGED; STATISTICS AS TOPIC;

EID: 79953154215     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. MURPHEY MD, GROSS TM, ROSENTHAL HG, From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation, Radiographics, 1994, 14(4):807-826; quiz 827-828.
2. KRANSDORF MJ, Benign soft-tissue tumors in a large referral population: distribution of specific diagnoses by age, sex, and location, AJR Am J Roentgenol, 1995, 164(2):395-402.
3. KRANSDORF MJ, MURPHEY MD, Radiologic evaluation of soft-tissue masses: a current perspective, AJR Am J Roentgenol, 2000, 175(3):575-587.
4. CODOREAN I, POPESCU A, BABALAC C, CODOREAN IB, DIACONESCU S, Studiu radioimagistic al sarcoamelor de pǎrţi moi ale membrelor, Revista Medicala Romania UPDATE, ianuarie-martie 1998, IV(1-3).
5. MOULTON JS, BLEBEA JS, DUNCO DM, BRALEY SE, BISSET GS 3RD, EMERY KH, MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions, AJR Am J Roentgenol, 1995, 164(5):1191-1199.
6. MURPHEY MD, KRANSDORF MJ, Soft tissue tumors, Eur Radiol, 2001, Suppl 2:S249-S258.
7. TUNG GA, DAVIS LM, The role of magnetic resonance imaging in the evaluation of the soft tissue mass, Crit Rev Diagn Imaging, 1993, 34(5):293-308.
8. DALDRUP H, SHAMES DM, WENDLAND M, OKUHATA Y, LINK TM, ROSENAU W, LU Y, BRASCH RC, Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and smallmolecular contrast media, AJR Am J Roentgenol, 1998, 171(4):941-949.
9. DE SCHEPPER AM, RAMON FA, DEGRYSE HR, Statistical analysis of MRI parameters predicting malignancy in 141 soft tissue masses, Rofo, 1992, 156(6):587-591.
10. KRANSDORF MJ, MURPHEY MD (eds), Imaging of soft tissue tumors, Saunders, Philadelphia, 1997.
11. HERMANN G, ABDELWAHAB IF, MILLER TT, KLEIN MJ, LEWIS MM, Tumour and tumour-like conditions of the soft tissue: magnetic resonance imaging features differentiating benign from malignant masses, Br J Radiol, 1992, 65(769):14-20.
12. MIROWITZ SA, TOTTY WG, LEE JK, Characterization of musculoskeletal masses using dynamic Gd-DTPA enhanced spin-echo MRI, J Comput Assist Tomogr, 1992, 16(1):120-125.
13. rd edition, Time Mirror International Publishers Ltd., London, 1997.
14. rd revised edition, University of Florida Press/J. Hillis Miller Health Science Center, Gainesville, Florida, 1990.
15. WOLF RE, ENNEKING WF, The staging and surgery of musculoskeletal neoplasms, Orthop Clin North Am, 1996, 27(3):473-481.
16. VANEL D, SHAPEERO LG, TARDIVON A, WESTERN A, GUINEBRETIÈRE JM, Dynamic contrast-enhanced MRI with subtraction of aggressive soft tissue tumors after resection, Skeletal Radiol, 1998, 27(9):505-510.
17. HUVOS AG, Bone tumors: diagnosis, treatment, and prognosis, W.B. Saunders Co., Philadelphia, 1991.
18. BERQUIST TH, EHMAN RL, KING BF, HODGMAN CG, ILSTRUP DM, Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions, AJR Am J Roentgenol, 1990, 155(6):1251-1255.
19. DE SCHEPPER A, PARIZEL P, RAMON F, DE BEUCKELEER L, VANDEVENNE JE (eds), Imaging of soft tissue tumors, Springer, Berlin-Heidelberg-New York, 1997.
20. th edition, Lippincott-Raven, Philadelphia, 1996.
21. FLEMING ID, Staging of pediatric cancers: problems in the development of a national system, Semin Surg Oncol, 1992, 8(2):94-97.
22. HOUGH T, TUNG G, TEREK R, Staging. In: DE SCHEPPER A, PARIZEL P, RAMON F, DE BEUCKELEER L, VANDEVENNE JE (eds), Imaging of soft tissue tumors, Springer, Berlin-Heidelberg-New York, 1997, 113-126.
23. VANDEVENNE JE, DE SCHEPPER AM, DE BEUCKELEER L, VAN MARCK E, APARISI F, BLOEM JL, ERKORKMAZ Z, BRIJS S, New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions, Eur Radiol, 1997, 7(7):1013-1019.
24. ERLEMANN R, REISER MF, PETERS PE, VASALLO P, NOMMENSEN B, KUSNIERZ-GLAZ CR, RITTER J, ROESSNER A, Musculoskeletal neoplasms: static and dynamic Gd-DTPA -enhanced MR imaging, Radiology, 1989, 171(3):767-773.
25. VERSTRAETE KL, DE DEENE Y, ROELS H, DIERICK A, UYTTENDAELE D, KUNNEN M, Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging - parametric "first-pass" images depict tissue vascularization and perfusion, Radiology, 1994, 192(3):835-843.
26. KRANSDORF MJ, Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location, AJR Am J Roentgenol, 1995, 164(1):129-134.
27. DE SCHEPPER AM, DE BEUCKELEER L, VANDEVENNE JE, Magnetic resonance of soft tissue tumors, Erasmus Course of Magnetic Resonance Imaging, 1995, 187-199.